Jobs
-
Submit call for papers form to hexagon@hexagon.dk or fax to +45 33 13 38 59. Read more . . .
-
Anyone interested in presenting should contact andrea.jandrea.james@management-forum.co.uk Read more . . .
-
Mangrove Partners, which holds approximately %5.7 of the outstanding shares of CPEX Pharmaceuticals, has announced that it will oppose the merger of CPEX with FCB, a wholly-owned subsidiary of Footstar Corporation. The merger was announced… Read more . . .
-
Savara Pharmaceuticals is seeking a high energy individual to fill a laboratory-based role in its formulation and analytical development laboratories. The successful candidate should be comfortable working in a start-up company and have experience supporting… Read more . . .
-
3M Drug Delivery Systems Division partners with pharmaceutical and biotech companies to develop pharmaceuticals using 3M’s inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with regulatory… Read more . . .
-
We are seeking a highly motivated, experienced scientist to join the Pharmaceutical Development group at our early-stage pharmaceutical company to provide technical leadership and hands-on performance. The ideal candidate will have expertise in dry powder… Read more . . .
-
An innovative, inhalation-focused development organisation with multiple UK sites is now looking for an Analytical Development Manager at their modern facility in the southwest of the UK. The successful candidate will lead an experienced team… Read more . . .
-
The laboratory groups at Catalent RTP are responsible for the support of pharmaceutical product development in a range of dosage forms both directly with customers and in collaboration with other Catalent facilities. This includes formulation… Read more . . .
-
The laboratory groups at Catalent RTP are responsible for the support of pharmaceutical product development in a range of dosage forms both directly with customers and in collaboration with other Catalent facilities. This includes formulation… Read more . . .
-
Numerous studies have described the difficulties patients experience in using metered dose inhalers (MDIs), including a recent article in the Journal of General Internal Medicine (JGIM) that found 86% of hospitalized patients enrolled in a… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK